Navigation Links
More Women Are Opting For Painless Labor

Research shows that more and more women are now opting for painless natural childbirth than before.

According to a new study in the September issue of the journal Anesthesiology, as pain control options for labor // and delivery become more varied and sophisticated, growing numbers of women are taking advantage of pain relief for their childbirth.

Researchers from the University of Colorado had looked at survey responses from 378 hospitals that provided obstetric services in 2001, grouping the hospitals according to the number of births per year (1,500 or more, 500-1,499 and fewer than 500). They found that only 6 to 10 percent of mothers had no pain relief (analgesia) during labor in 2001, compared to 11 to 33 percent in 1992. Hospitals doing more deliveries generally had fewer mothers going without anesthesia in both years.

As women have embraced techniques that can make them more comfortable for more of their labor, demand for anesthesia services in hospitals is growing as well. Most anesthesias for labor and Cesarean delivery was directly provided or supervised by anesthesiologists. In hospitals providing care for 1,500 or more births during 2001, an anesthesiologist was involved in 95 percent of cases. Other providers of anesthesia care include certified registered nurse anesthetists and, in a very small percentage of cases, obstetricians.

Regional analgesia, including epidural, spinal or combined epidural-spinal techniques, accounted for 76 percent of the anesthesia services provided in the larger hospitals, and for 57 percent of services in the smaller hospitals. These figures represent a significant increase since 1992. Mothers are less likely to receive parenteral narcotics (drugs injected into the blood stream) as their only source of pain relief.

Source: Newswise
'"/>




Page: 1

Related medicine news :

1. Women suffer from sexual dysfunction too
2. Women find difficulty in calling it Quits
3. Women recognise faces better
4. Women more susceptible to brain damage from ecstasy
5. Good News For Women With Gestational Diabetes
6. Unsatisfactory Grade On Womens Health Issues
7. Risk for Pregnant Women
8. Womens strong sense of smell
9. Women need to exercise more to prevent obesity
10. Women benefit from consuming fish
11. Women are at risk with raised cholesterol

Post Your Comments:
*Name:
*Comment:
*Email:
TAG: More Women Are Opting For Painless Labor

(Date:11/9/2009)... may be left atrial enlargement, study finds , ...y is a major risk factor for left atrial enlargeme...n, stroke and death, a new study shows. , Atria...ia (an irregular heart rhythm or heartbeat). ,... aged 25 to 74, in Germany who were followed for 1...
(Date:11/9/2009)...ikely due to fact that both eye conditions are age...v. 9 (HealthDay News) -- Cataract surgery doesn,t ...ular degeneration (AMD), according to a new study ... of vision loss worsens the other. , "Because b...viduals with cataract also have AMD," wrote Li Min...
(Date:11/9/2009)...y of care increases with longer doctor visits, res...ay News) -- Family doctors are now taking more tim... often and improving the quality of visits, a new ...h their primary care physicians during office visi...and overall they seemed to receive better care," s...
(Date:11/9/2009)... Course, to be Offered in April...oolkit , Cambridge, MA (V...hysicians for Human Rights (PHR) first inspected a...stan , he realized he would need a team of experts...ting the site properly was a key first step in sec...
(Date:11/9/2009)...LEBANON, Tenn., Nov. 9 Health Conn...ounced it will host their inaugural Hospital O.R. ...10 at the Marriott Renaissance Hotel in Nashville,...more than 100 hospital operating room directors an...health systems in the country. Some of the confirm...
Breaking Medicine News(10 mins):Health News:Cataract Surgery Doesn't Worsen Macular Degeneration: Study 2Health News:Doctors Spending More Time Now With Patients 2Health News:Doctors Spending More Time Now With Patients 3Health News:Physicians for Human Rights Offers Training in Crime Scene Documentation 2Health News:Physicians for Human Rights Offers Training in Crime Scene Documentation 3Health News:Physicians for Human Rights Offers Training in Crime Scene Documentation 4Health News:Health Connect Partners Hosts Hospital O.R. & Surgery Center Conference 2
...f money, and ,lack of time, as, the top three fac...hing changes that benefit their ...rom a survey,released today reveal that the vast m...e actually successful. The,survey, commissioned by...
...a precarious time, as about 15 percent of women wh...ry. This risk increases when pregnant women underg...ry (HSS) in New York instituted a same-day pregnan...regnancies to the benefit of the patient, the phys...
...s of Biovail,Corporation (NYSE: BVF )(TSX: BVF) t...EO of Biovail Corporation:, , June 16, 2008, Wil...ration 7150 Mississauga Road Mississauga, Ontari...ovail shareholders have an important decision to m...
...the American Medical Association (AMA), Patrick W....MA,s Council of Ethical and Judicial Affairs,(CEJA...cal and Judicial Affairs (CEJA) develops ethics,po...address timely ethical issues that confront physic...
...of hot flashes that they experience by more than 4...r verbal memory, according to a study by researche...e study is published online and will appear in the... memory performance. , Memory complaints are comm...
... bound for baldness , , MONDAY, June 16 (H...e losing? , Start counting -- the hairs on your c...chives of Dermatology , scientists demonstrate tha...ch can be carried out in the convenience of your o...
Other Medicine News:Health News:LIVESTRONG.COM Survey Reveals 86 Percent of Americans Attempt Changes to Improve Their Health but Less Than Half are Successful 2Health News:LIVESTRONG.COM Survey Reveals 86 Percent of Americans Attempt Changes to Improve Their Health but Less Than Half are Successful 3Health News:LIVESTRONG.COM Survey Reveals 86 Percent of Americans Attempt Changes to Improve Their Health but Less Than Half are Successful 4Health News:Same-day pregnancy test provides valuable guidance to pre-surgery patients 2Health News:Letter Challenges Biovail CEO to a Debate 2Health News:Letter Challenges Biovail CEO to a Debate 3Health News:Hot flashes underreported and linked to forgetfulness 2Health News:Countdown to Hair Loss 2Health News:Countdown to Hair Loss 3
(Date:11/9/2009)...v. 9 /PRNewswire-Asia-FirstCall/ -- American Orien...any" or "AOBO"), a pharmaceutical,company dedicate...ufacture and,commercialization of a broad range of...s, today announced that it plans to release third ... 16, 2009, after the market closes. , The...
(Date:11/9/2009)...N.J., Nov. 9 Par Pharmac...ced that it has extended the expiration date and i...unced "Modified Dutch Auction" tender offer, in wh...65,000,000 aggregate principal amount, or up to ap...r Subordinated Convertible Notes due 2010. ,, T...
(Date:11/9/2009)...9, 2009 Arena Pharmaceut...ial results for the third quarter ended September ...locable to common stockholders in the third quarte...mpared to a net loss allocable to common stockhold... or $0.76 per share, and a net loss allocable to c...
Breaking Medicine Technology:Par Pharmaceutical Announces Extension and Increase in Maximum Purchase Price for 'Modified Dutch Auction' Tender Offer to Purchase up to $65,000,000 Aggregate Principal Amount of its Currently Outstanding 2.875% Senior Subordinated Convertible Note 2Par Pharmaceutical Announces Extension and Increase in Maximum Purchase Price for 'Modified Dutch Auction' Tender Offer to Purchase up to $65,000,000 Aggregate Principal Amount of its Currently Outstanding 2.875% Senior Subordinated Convertible Note 3Arena Pharmaceuticals Announces Third Quarter 2009 Financial Results and Recent Developments 2Arena Pharmaceuticals Announces Third Quarter 2009 Financial Results and Recent Developments 3Arena Pharmaceuticals Announces Third Quarter 2009 Financial Results and Recent Developments 4Arena Pharmaceuticals Announces Third Quarter 2009 Financial Results and Recent Developments 5Arena Pharmaceuticals Announces Third Quarter 2009 Financial Results and Recent Developments 6Arena Pharmaceuticals Announces Third Quarter 2009 Financial Results and Recent Developments 7Arena Pharmaceuticals Announces Third Quarter 2009 Financial Results and Recent Developments 8Arena Pharmaceuticals Announces Third Quarter 2009 Financial Results and Recent Developments 9Customers Design Reid Supply 26apos 3Bs New Web Site 50846 1Customers Design Reid Supply 26apos 3Bs New Web Site 50846 2Customers Design Reid Supply 26apos 3Bs New Web Site 50846 3Customers Design Reid Supply 26apos 3Bs New Web Site 50846 4Customers Design Reid Supply 26apos 3Bs New Web Site 50846 5MRI accurately depicts deep endometriosis 50842 1MRI accurately depicts deep endometriosis 50842 2SoundBite 28TM 29 Hearing System by Sonitus Medical Receives First Acceptance for Publication in Otology 26 Neurotology Journal 50838 1SoundBite 28TM 29 Hearing System by Sonitus Medical Receives First Acceptance for Publication in Otology 26 Neurotology Journal 50838 2SoundBite 28TM 29 Hearing System by Sonitus Medical Receives First Acceptance for Publication in Otology 26 Neurotology Journal 50838 3
...t and Phase 1b Combination Clinical Trials ...y, SOUTH SAN FRANCISCO, Calif., June 16 Sunesis,...ata Saturday from two,clinical trials of the compa...595), including updated results of a Phase 1 trial...sed or refractory patients with acute,myeloid leuk...
...Pharmaceuticals,Inc. (Amex: ANX ) today provided ... Phase 2b clinical trial of CoFactor for the treat...verall survival results in this,study have been re...fluorouracil) arm demonstrating a 14 day improveme...5-FU arm., "In the Phase 2b study, CoFactor was d...
Other Medicine Technology:Sunesis Pharmaceuticals Presents Data from Clinical Trials of Voreloxin (formerly SNS-595) in Patients with Acute Myeloid Leukemia at the 13th Congress of the European Hematology Association 2Sunesis Pharmaceuticals Presents Data from Clinical Trials of Voreloxin (formerly SNS-595) in Patients with Acute Myeloid Leukemia at the 13th Congress of the European Hematology Association 3Sunesis Pharmaceuticals Presents Data from Clinical Trials of Voreloxin (formerly SNS-595) in Patients with Acute Myeloid Leukemia at the 13th Congress of the European Hematology Association 4Sunesis Pharmaceuticals Presents Data from Clinical Trials of Voreloxin (formerly SNS-595) in Patients with Acute Myeloid Leukemia at the 13th Congress of the European Hematology Association 5Sunesis Pharmaceuticals Presents Data from Clinical Trials of Voreloxin (formerly SNS-595) in Patients with Acute Myeloid Leukemia at the 13th Congress of the European Hematology Association 6ADVENTRX Announces CoFactor(R) Phase 2b Clinical Trial Overall Survival Results 2ADVENTRX Announces CoFactor(R) Phase 2b Clinical Trial Overall Survival Results 3
Utility & Splinter Forceps #H
Evisceration Disposible Sizers
Straight Iris Forceps
Semkin Forceps with stops
Medicine Products: